Clinical Trial Update: A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of a single oral dose of 14C-OSI-906 in patients with solid tumors, examining absorption, metabolism, and elimination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• OSI-906 (OSI-906)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Advanced Solid Tumors, Pharmacokinetics of 14C-OSI-906 | Phase 1 | Status: COMPLETED